
    
      This is a multi-center, open-label, Simon's 2-stage, phase II study of paclitaxel and
      cisplatin as neoadjuvant therapy in patients with FIGO IB2 or IIA2, squamous cell cervical
      carcinoma of the uterine cervix.

      Primary Objectives:

      â€¢ Overall survival

      Secondary Objectives:

        -  Safety

        -  Progression-free survival

        -  Response rate

        -  Postoperative RT/CRT rate

        -  To assess Quality-of-life

      An estimate of 64 evaluable patients will be enrolled in this phase II investigation.
    
  